In the year since COVID-19 brought all normal activity to a halt, clinical trial professionals around the world have been forced to re-examine their strategies. What happens when neither patients nor clinical research associates can visit trial sites? How can data collection and data monitoring occur — and critically, how can researchers deliver clean, concise results that meet regulatory approval standards?
One simple solution: Maximize the usage of mobile health (mHealth) devices and remote monitoring to collect and manage data.